News
They won’t help you search the Internet, but Kubota Vision’s glasses may help slow the progression of myopia, and possibly even prevent the condition when…
Read More
The OIS Index of ophthalmic stocks declined 0.4% in August, underperforming its benchmark indices for the second straight month. The NASDAQ Biotechnology Index posted a…
Read More
Ophthalmology drugs, particularly drugs associated with surgeries and retinal disease, took a beating in Q2 because of COVID-19 disruptions. Things may be looking up for…
Read More
The population of US dry eye patients is greatly underserved, but innovative treatments in development are poised to provide more treatment options and capture at…
Read More
As Applied Genetic Technologies Corp. takes the next steps in the development of its lead gene therapy candidate for inherited retinal disease, the company has…
Read More
As Bausch Health pursues a spin-off of its eye health business into an independent company, it’s following a playbook that’s scored well in ophthalmology, and…
Read More
Last month, the US Food and Drug Administration approved a novel ophthalmic solution to treat acquired blepharoptosis, otherwise known as “droopy lid syndrome.” The solution,…
Read More
The American Society of Retina Specialists annual scientific meeting went virtual this year, but that didn’t diminish the multitude of reports on retina treatments in…
Read More
In this time of virtual meetings, the Ophthalmology Innovation Summit (OIS) continues to deliver information and foster innovation. Last week’s OIS Virtual Public Company Showcase…
Read More
Almost 200 – precisely 196 at last count – industry-sponsored clinical trials for retinal diseases are underway, based on a clinicaltrials.gov search. It’s safe to…
Read More
The OIS Index of ophthalmic stocks staged a strong comeback in Q2, gaining 21.4%, in line with the overall US stock market as measured by…
Read More
Weeks after completing its acquisition of Allergan, AbbVie is seeking a meeting with the US Food and Drug Administration to talk about the next steps…
Read More
SUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.
![OIS-ANTERIOR-NEW-DATE-750x420[4300]](https://ois.net/wp-content/uploads/2020/03/OIS-ANTERIOR-NEW-DATE-750x4204300.jpg "OIS-ANTERIOR-NEW-DATE-750x420[4300]")